Why choose the treatment with cisplatin for BRCA1 breast cancers patients?

by Byrski, T, Huzarski, T, Marczyk, E, Blecharz, P, Gronwald, J, Ashuryk, O, Cybulski, C, Dębniak, T, Zuziak, D, Godlewski, D, Kladny, J, Lubinski, J, Narod, SA
Published 2012

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

by Byrski, T, Gronwald, J, Huzarski, T, Dent, RA, Zuziak, D, Wiśniowski, R, Marczyk, E, Blecharz, P, Szurek, O, Cybulski, C, Dębniak, T, Górski, B, Lubiński, J, Narod, S
Published 2011

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment

by Byrski, T, Gronwald, J, Huzarski, T, Marczyk, E, Blecharz, P, Ashuryk, O, Cybulski, C, Zuziak, D, Wiśniowski, R, Godlewski, D, Narod, SA, Lubiński, J
Published 2012

Selenium and the risk of cancer in BRCA1 carriers

by Lubinski, J, Jaworska, K, Durda, K, Jakubowska, A, Huzarski, T, Byrski, T, Stawicka, M, Gronwald, J, Górski, B, Wasowicz, W, Kilar, E, Szwiec, M, Surdyka, D, Marczyk, E, Sun, P, Narod, SA
Published 2011

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

by Wojcik, P., Jasiowka, M., Strycharz, E., Sobol, M., Hodorowicz-Zaniewska, D., Skotnicki, P., Byrski, T., Blecharz, P., Marczyk, E., Cedrych, I., Jakubowicz, J., Lubiński, J., Sopik, V., Narod, S., Pierzchalski, P.
Published 2016

Impact of BRCA1 mutation on survival after early onset breast cancer

by Huzarski, T, Byrski, T, Gronwald, J, Górski, B, Domagała, W, Cybulski, C, Sun, Ping, Oszurek, O, Szwiec, M, Gugała, K, Stawicka, M, Morawiec, Z, Mierzwa, T, Janiszewska, H, Kilar, E, Marczyk, E, Kozak-Klonowska, B, Siołek, M, Surdyka, D, Wiśniowski, R, Posmyk, M, Lubiński, J, Narod, SA
Published 2012